Biphasic control of nuclear factor‐χB activation by the T cell receptor complex: role of tumor necrosis factor α
Authors:
- Pimentel‐ MuiñosPMPimentel‐ Muiños
- Felipe X.FXFelipe X.
- Javier MazanaJMJavier Mazana
- Manuel FresnoMFManuel Fresno
- 1 January 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (1) , 179-186
Abstract
The regulation of nuclear factor (NF)‐χB activation by the T cell receptor (TcR)/CD3 complex in primary human T cells has been studied at various times after activation. Only p50 NF‐χB protein bound the χB element of interleukin‐2 receptor (IL‐2R) α chain promoter on resting T cells. However, immediately after TcR/CD3 cross‐linking (after approximately 1 h; immediate) binding of p50.p65 heterodimers was observed. p50.c‐rel heterodimers were also detected bound to this sequence at early time points (7–16 h; early), and both remained active at later time points (40 h; late) after activation. This regulation takes place mainly at the level of nuclear translocation of p65 and c‐rel, at immediate and early time points. Activation also induced c‐rel and p105/p50 mRNA synthesis, but not p65 mRNA whose expression was constitutive. Interestingly, all those early and late events, but not the immediate ones, were inhibited by a neutralizing anti‐tumor necrosis factor α (TNF‐α) monoclonal antibody. Similarly, cycloheximide prevented the p65 and c‐rel translocation and consequent formation of active binding heterodimers, at early and late times. Cyclosporin A impaired not only early and late, but also immediate events; however, addition of TNF‐α prevented all inhibition. These results indicate that the regulation of NF‐χB activation during T cell activation by TcR/CD3 signals is biphasic: TcR/CD3 triggers its immediate translocation, which is transient if no TNF‐α is present. TNF‐α, therefore, emerges as the main factor responsible for a second phase of NF‐χB regulation, controlling both translocation of p65 and c‐rel, and new mRNA synthesis for c‐rel and p105/p50.Keywords
This publication has 56 references indexed in Scilit:
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- Regulation of the NF-ηB/rel transcription factor and IηB inhibitor systemCurrent Opinion in Cell Biology, 1993
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB functionCell, 1990
- Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsalCell, 1990
- The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene productCell, 1990
- Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing LinkAnnual Review of Immunology, 1990
- Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genesInternational Immunology, 1989
- The Interleukin-2 T-Cell System: A New Cell Growth ModelScience, 1984
- Isolation of B and T Lymphocytes by Nylon Fiber ColumnsTissue Antigens, 1977